canagliflozin 50 MG / metformin hydrochloride 500 MG [Invokamet]
RxNorm concept 1545165, branded drug component (sbdc).
- RxCUI
- 1545165
- Term type
- Branded drug component (SBDC)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1545165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
canagliflozin 50 MG / metFORMIN hydrochloride 500 MG [Invokamet]
Related concepts
- canagliflozin 50 MG / metformin hydrochloride 500 MG Oral Tablet [Invokamet] (SBD, constitutes)
- 24 HR canagliflozin 50 MG / metformin hydrochloride 500 MG Extended Release Oral Tablet [Invokamet] (SBD, constitutes)
- Invokamet (BN, has ingredient)
- metformin hydrochloride 500 MG (SCDC, tradename of)
- canagliflozin 50 MG (SCDC, tradename of)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 1545165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1545165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1545165. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.